dihexa clinical trial human studies trials Dihexa First in human trial |
Description
Yes, oral crystalline B12 typically 1,000 micrograms of cyanocobalamin daily is usually the first-line approach after gastric banding, as the absorptive anatomy remains intact
L., Van Itallie, C
A- Yes, it is often used for diabetic neuropathy and is regarded as safe
By blocking cAMP from binding to the HCN2 channel, it effectively releases the accelerator pedal without disrupting other vital cellular pathways
